Edition:
United Kingdom

Alkem Laboratories Ltd (ALKE.NS)

ALKE.NS on National Stock Exchange of India

1,965.35INR
23 May 2018
Change (% chg)

Rs45.15 (+2.35%)
Prev Close
Rs1,920.20
Open
Rs1,921.00
Day's High
Rs1,973.65
Day's Low
Rs1,904.55
Volume
50,284
Avg. Vol
35,536
52-wk High
Rs2,469.00
52-wk Low
Rs1,578.30

Chart for

About

Alkem Laboratories Limited is a pharmaceutical company. The Company is engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products. The Company operates through two segments: pharmaceutical and investing. The Company produces generics, generic drugs, active pharmaceutical ingredients (APIs) and... (more)

Overall

Beta: --
Market Cap(Mil.): Rs221,380.59
Shares Outstanding(Mil.): 119.57
Dividend: 9.00
Yield (%): 0.81

Financials

  ALKE.NS Industry Sector
P/E (TTM): 30.54 30.95 32.75
EPS (TTM): 60.62 -- --
ROI: -- 14.84 14.38
ROE: -- 16.34 16.07

India's Alkem Labs gets USFDA report about Amaliya unit

India's Alkem Labs Ltd said on Wednesday the United States Food and Drug Administration (USFDA) has issued a report about its Amaliya facility, citing 13 observations following an inspection.

28 Mar 2018

India's Alkem Labs gets USFDA report about Amaliya unit

March 28 India's Alkem Labs Ltd said on Wednesday the United States Food and Drug Administration (USFDA) has issued a report about its Amaliya facility, citing 13 observations following an inspection.

28 Mar 2018

BRIEF-Alkem Laboratories Gets Form 483 With 13 Observations After U.S. FDA Inspection At Co's Amaliya Facility​

* GOT A FORM 483 WITH 13 OBSERVATIONS AFTER US FDA INSPECTION AT CO'S MANUFACTURING FACILITY AT AMALIYA, DAMAN​

28 Mar 2018

BRIEF-India's Alkem Laboratories Dec Qtr Consol Profit Falls

* DEC QUARTER CONSOL PROFIT 1.72 BILLION RUPEES VERSUS 2.33 BILLION RUPEES YEAR AGO

09 Feb 2018

BRIEF-Alkem Laboratories Announces Closure of U.S.FDA Inspection at Baddi Manufacturing Facility

* SAYS U.S. FDA ISSUES EIR FOR CO'S MANUFACTURING FACILITY AT BADDI

10 Jan 2018

BRIEF-India's Alkem Laboratories Gets Shareholders' Nod For Appointment Of Sandeep Singh As MD

* GETS SHAREHOLDERS' NOD FOR APPOINTMENT OF SANDEEP SINGH AS MD

08 Jan 2018

BRIEF-Alkem Labs Seeks Shareholders' Nod To Appoint Sandeep Singh As MD

* SEEKS SHAREHOLDERS' NOD TO RE-APPOINT DHANANJAY KUMAR SINGH AS JOINT MD Source text - http://bit.ly/2jn04KA Further company coverage:

07 Dec 2017

Earnings vs. Estimates